The Indian government is laying the groundwork for the Data Protection Board, including appointing members and developing ...

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several ...

A new House Oversight Committee report takes aim at Washington D.C.‘s Metropolitan Police Department Chief Pamela Smith, accusing Smith of manipulating the district’s crime data. The Oversight ...

Arcus Biosciences Inc. and partner Gilead Sciences Inc. are scrapping phase III work with anti-TIGIT antibody domvanalimab after an independent data monitoring committee said the drug will fail in ...

Sustainability program committee recommends GSU well monitoring proposal for approval Lawmakers react to US seizure of Venezuelan oil tanker After winning his first Oscar, Tom Cruise kept repeating ...

RESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (IRD) (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...

RESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month. SENS-501 (OTOF-GT) is an innovative gene therapy program developed to treat a specific ...